These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18193927)

  • 61. Effect of topiramate on intractable seizures in Taiwanese children.
    Li ST; Shen EY; Chiu NC; Ho CS
    Acta Neurol Taiwan; 2004 Jun; 13(2):59-63. PubMed ID: 15478676
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A pilot study of topiramate in children with Lennox-Gastaut syndrome.
    Guerreiro MM; Manreza ML; Scotoni AE; Silva EA; Guerreiro CA; Souza EA; Ferreira VB; Reed UC; Diament A; Trefiglio R; Chiu HC; Bacaltchuk J
    Arq Neuropsiquiatr; 1999 Jun; 57(2A):167-75. PubMed ID: 10412513
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study.
    Ramsay RE; Uthman B; Pryor FM; Rowan AJ; Bainbridge J; Spitz M; Sirven JI; Frederick TE
    Epilepsia; 2008 Jul; 49(7):1180-5. PubMed ID: 18494791
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
    Goa KL; Ross SR; Chrisp P
    Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Topiramate: a broad-spectrum antiepileptic drug? Sixth meeting of the European Neurological Society. Den Haag, 8 June 1996].
    Fortschr Neurol Psychiatr; 1996 Sep; 64(9 Suppl):1-8. PubMed ID: 9022373
    [No Abstract]   [Full Text] [Related]  

  • 67. Topiramate in patients with juvenile myoclonic epilepsy.
    Biton V; Bourgeois BF;
    Arch Neurol; 2005 Nov; 62(11):1705-8. PubMed ID: 16286543
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Topiramate: new indication. A bulkier assessment file.
    Prescrire Int; 1999 Oct; 8(43):141-2. PubMed ID: 11503838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom.
    Verdian L; Yi Y
    Seizure; 2010 Jan; 19(1):1-11. PubMed ID: 19942457
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Topamax in monotherapy of epilepsy].
    Mukhin KIu; Glukhova LIu; Petrukhin AS; Mironov MB; Sobornova AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):35-40. PubMed ID: 15554140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Topamax monotherapy of partial epilepsy].
    Kalinin VV; Zheleznova EV; Sokolova LV; Rogacheva TA; Polianskiĭ DA; Zemlianaia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(7):35-8. PubMed ID: 15347032
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Changes of body weight and galanin in epileptic children treated with topiramate].
    Shi RF; Wang KL; Li QH; Zheng HC; Yang HF; Tang HX; Sun SZ; Wang LH; Tian J
    Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):199-202. PubMed ID: 17504624
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Topiramate in monotherapy or in combination as a cause of metabolic acidosis in adults with epilepsy].
    Ruiz-Granados VJ; Márquez-Romero JM
    Rev Neurol; 2015 Feb; 60(4):159-63. PubMed ID: 25670045
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
    Shank RP; Maryanoff BE
    CNS Neurosci Ther; 2008; 14(2):120-42. PubMed ID: 18482025
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Topamax in the treatment resistance partial epilepsy].
    Kalinin VV; Zheleznova EV; Sokolova LV; Rogacheva TA; Polianskiĭ DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(9):48-53. PubMed ID: 14571674
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers.
    Mecarelli O; Piacenti A; Pulitano P; Vicenzini E; Rizzo C; Rinalduzzi S; de Feo MR; Accornero N
    Clin Neuropharmacol; 2001; 24(5):284-9. PubMed ID: 11586113
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Dynamics of clinical, neurophysiological and radiological indices as a criterion for evaluation of treatment quality of symptomatic epilepsy with keppra and topamax].
    Shershever AS; Lavrova SA; Telegin AV; Grib AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(7):15-9. PubMed ID: 18379476
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Efficacy of topiramate (topamax) in epileptic patients of different age].
    Voronkova KV; Pyleva OA; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):34-7. PubMed ID: 16841481
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic.
    Kellett MW; Smith DF; Stockton PA; Chadwick DW
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):759-63. PubMed ID: 10329750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.